Glioma: all 1,425 studies
Page 8 of 15. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.
- Intraoperative Sonographically Versus Fluorescence-guided Resection of Contrast-enhancing Gliomas and Brain MetastasesSuspendedNCT05475522Not applicable
- PTCs-based Precision Treatment Strategy on Recurrent High-grade GliomasActive, not recruitingNCT05473923Early Phase 1
- Intraoperative Sonographically Guided Resection of Non-enhancing GliomasSuspendedNCT05470374Not applicable
- Efficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal MetastasesStatus unknownNCT05459441Early Phase 1
- Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutantWithdrawnNCT05457959Phase 1
- Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid TumorsTerminatedNCT05429502Phase 1
- Niraparib In Recurrent IDH 1/2 GliomasActive, not recruitingNCT05406700Early Phase 1
- AsiDNA Children, Adolescents and Young AdultsTerminatedNCT05394558Phase 1/2
- Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant GliomasCompletedNCT05393258Not applicable
- Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine GliomasNo longer availableNCT05392374
- Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain TumorsCompletedNCT05383872Not applicable
- BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological LevelsCompletedNCT05375318
- Evaluation of Cognitive and Motor Neurological Disorders in the Short and Long Term After Surgery for the Removal of a Diffuse Low-grade Glioma of the Supplementary Motor AreaCompletedNCT05373394
- The KetoGlioma (Ketogenic Glioma) StudyWithdrawnNCT05373381Not applicable
- Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade GliomaCompletedNCT05362409Phase 1
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.Active, not recruitingNCT05355701Phase 1
- GammaTile and Stupp in Newly Diagnosed GBMActive, not recruitingNCT05342883Phase 4
- Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent GlioblastomaWithdrawnNCT05341947Phase 1
- Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood FlowCompletedNCT05305378
- An Integrated Radio-immunological ApproachActive, not recruitingNCT05267509
- GROW (Glioma Specialists Reaching Out With Support) SupportWithdrawnNCT05233215Not applicable
- ALBATROSS Study: International Multicenter Study for Prospective Validation of Imaging Biomarkers Calculated at Vascular Habitats of High-grade GliomasCompletedNCT05229198
- Safety and Tolerability of Fb-PMT in Recurrent GlioblastomaActive, not recruitingNCT05226494Phase 1
- Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 AlterationsWithdrawnNCT05222165Phase 1/2
- A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsCompletedNCT05199584Phase 2
- AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma PatientsActive, not recruitingNCT05182905Early Phase 1
- hPG80 (Circulating Progastrin) as a Blood Biomarker for High-grade Glial TumorsCompletedNCT05157594
- Strategic Intervention on Preserving Motor Function During Awake CraniotomyStatus unknownNCT05143788Not applicable
- Strategic Intervention on Preserving Language Function During Awake CraniotomyStatus unknownNCT05143775Not applicable
- LIQUID BIOPSY IN Low-grade Glioma PatientsActive, not recruitingNCT05133154Not applicable
- A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPGSuspendedNCT05123534Phase 2
- Clinical Evaluation of Genetron TERT PCR Kit in Glioma PatientsCompletedNCT05100602
- Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma PatientsCompletedNCT05100173
- A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)SuspendedNCT05099003Phase 1/2
- A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)Active, not recruitingNCT05094336Phase 1/2
- A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade GliomasWithdrawnNCT05082493Phase 1
- Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent GliomaActive, not recruitingNCT05076513Early Phase 1
- The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in PatientsStatus unknownNCT05063682Phase 1
- Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent GliomaWithdrawnNCT05061251Early Phase 1
- Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent GliomaActive, not recruitingNCT05045027Early Phase 1
- Quality of Life and Patient Needs in Advanced High Grade GliomasCompletedNCT05039346
- Study of DSP-0390 in Patients With Recurrent High-Grade GliomaActive, not recruitingNCT05023551Early Phase 1
- fMRI Study of Functional Reorganization in Glioma PatientsStatus unknownNCT05019196
- Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM PatientsCompletedNCT04998864
- Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM PatientsCompletedNCT04988750Not applicable
- Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State NetworksActive, not recruitingNCT04975139
- Expression of ANXA2 in the Extracellular Space in the Microenvironment of Periumoral Edema Promotes Glioma InvasionStatus unknownNCT04953468
- Personalized Vaccine for Patients With Recurrent Malignant GliomaStatus unknownNCT04943718Phase 1
- The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics EvaluationCompletedNCT04937413Early Phase 1
- Pilot Study Evaluating the Optimization of the ORBEYE Blue Light Filter During Fluorescence-Guided Resection of GliomasStatus unknownNCT04937244Phase 4
- Molecular Pathology Research Project of GliomaCompletedNCT04924127
- Histomolecular Profiles of Gliomas in Children and Adolescent/Young AdultsCompletedNCT04916015
- Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine GliomaCompletedNCT04911621Phase 1/2
- How the Precise Habitats Can Predict the IDH Mutation Status and Prognosis of the Patients With High-grade GliomasStatus unknownNCT04908267
- Multi-center Research Project for Glioma Molecular Pathology Intraoperative Rapid DetectionCompletedNCT04904419
- Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to ApixabanTerminatedNCT04895553
- [18F] FDOPA PET Imaging in Glioma: Feasibility Study for PET Guided Brain BiopsyActive, not recruitingNCT04870580Not applicable
- NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade GliomaTerminatedNCT04851834Phase 1/2
- ASP8374 + Cemiplimab in Recurrent GliomaCompletedNCT04826393Phase 1
- A Study of Anlotinib in the Treatment of Recurrent High-grade GliomaStatus unknownNCT04822805Phase 2
- Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or GliosarcomaCompletedNCT04817254Phase 2
- Does Notch Regulate Glioma Proliferation ?CompletedNCT04809597
- A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated GliomasActive, not recruitingNCT04808245Phase 1
- Research on Precise Immune Prevention and Treatment of Glioma Based on Multi-omics Sequencing DataStatus unknownNCT04792437
- Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant GliomaTerminatedNCT04782609Phase 1
- The Study of Microglia/Macrophages Involved Dynamic Evolution of Glioma Microenvironment and the Function and Visualization of Targeted Molecules of GliomaStatus unknownNCT04781764
- A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA SignalingCompletedNCT04773782Phase 1/2
- A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG)TerminatedNCT04771897Phase 1
- Contribution of Cerebral 18F-DOPA PET-CT Scan in High-grade Recurrent GliomasCompletedNCT04766632Not applicable
- Neoantigen Vaccine Therapy Against H3.3-K27M Diffuse Intrinsic Pontine GliomaCompletedNCT04749641Phase 1
- Monocyte Antigen Carrier Cells for Newly Diagnosed GBMWithdrawnNCT04741984Phase 1
- Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRdCompletedNCT04740190Phase 2
- Post-operative Imaging in High Grade Glioma: is Management Influenced?Status unknownNCT04738110
- Glioma Supra Marginal Incision TrialCompletedNCT04737577Not applicable
- Chronotherapy for Radiotherapy of GliomaStatus unknownNCT04735939
- SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain TissueCompletedNCT04734444Not applicable
- MR Textural Analysis in Low Grade GliomasCompletedNCT04719806
- Transcranial Magnetic Stimulation in the Rehabilitation of Postoperative Motor Dysfunction.Status unknownNCT04706338Not applicable
- Multimodal Machine Learning Characterization of Solid TumorsCompletedNCT04687969
- Anlotinib to Malignant Brainstem GliomaStatus unknownNCT04668508Phase 2
- Safety and Effectiveness of Blood-Brain Barrier Disruption (BBBD) in Subjects With Suspected Infiltrating GliomaWithdrawnNCT04667715Not applicable
- Study of Recombinant Human Endostatin Combined With CV Regimen in the Treatment of Pediatric Low-grade GliomasCompletedNCT04659421Phase 2
- Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their CaregiversCompletedNCT04630379Not applicable
- Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline GliomasApproved for marketingNCT04617002
- Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical ResectionTerminatedNCT04608812Phase 1
- Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade GliomaStatus unknownNCT04588987Phase 2
- Role of Surgery in Treatment of Recurrent Brian Glioma:Prognostic Factors and OutcomeStatus unknownNCT04562077
- Study of Sonodynamic Therapy in Participants With Recurrent High-Grade GliomaTerminatedNCT04559685Early Phase 1
- Enhanced Detection in Glioma ExcisionTerminatedNCT04556929Not applicable
- Seizures During Radiotherapy for High-grade GliomasTerminatedNCT04552756Not applicable
- HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBMStatus unknownNCT04547621Phase 1/2
- Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsTerminatedNCT04541225Phase 1
- Glioma Brain Tumours - E12513 - SensiScreen GliomaStatus unknownNCT04539431
- Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in ChildrenStatus unknownNCT04532229Phase 3
- Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain CancerWithdrawnNCT04521946Phase 1
- Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsActive, not recruitingNCT04521686Phase 1
- HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade GliomaWithdrawnNCT04482933Phase 2
- Evaluation of the Use of Radiomics in 18F-FDOPA PET Examinations for the Characterization of GliomasCompletedNCT04469244
- Characterization of Metabolic Changes in the Glioma Tumor Tissue Induced by Transient Fasting (ERGO3)Active, not recruitingNCT04461938Not applicable
- Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.CompletedNCT04461002